|Page (1) of 1 - 06/12/18||email article||print page|
Atlas Growers retains Investor Relations Services(June 12, 2018)
EDMONTON, Alberta, June 12, 2018 (GLOBE NEWSWIRE) -- ATLAS GROWERS LTD. (“Atlas”) announces the retention of Colwell Capital Corp. (“Colwell”) to provide ongoing strategic investor relations services. The advisory services to be provided will include expanding Atlas’ presence with the Canadian brokerage and investment community, managing the Atlas shareholder base, organizing management road-show presentations, assisting with the overall strategy for corporate communications, and sourcing financing to fund Atlas’ growth plans.
Colwell is a Calgary-based investor relations firm founded by Mr. Graeme Dick and has represented public and private clients in the biotechnology, technology, resource and industrial sectors for 19 years. Colwell focuses on introducing high-quality investment opportunities, such as Atlas, to its retail, institutional, analyst and media networks. Colwell will be assisted by Boardmarker Group, a Canadian consulting firm owned and operated by Mr. Dean Stuart, an acknowledged capital markets expert with over 20 years of experience in investor relations and investment banking.
“We are pleased to welcome Colwell to the Atlas team. This is an exciting time for Atlas and we look forward to working with Colwell to expand our story throughout Canada and internationally,” stated Sheldon Croome, Atlas President & CEO.
Mr. Graeme Dick, President of Colwell, noted “Mr. Stuart and I have had the opportunity to meet the Atlas team and tour their world-class facility which is nearing completion NW of Edmonton. Further, Jim Hole, Atlas VP Cultivation, delivers Atlas a significant competitive advantage regarding facility design, construction and operation. This will yield the highest quality of production, and aid Atlas to become a global leader in the production and sale of medical cannabis and related products.”
About Atlas Growers Ltd.
Atlas Growers Ltd. (“Atlas”) is based in Edmonton, Alberta, Canada and is a wholly owned subsidiary of Atlas Biotechnologies Inc. Atlas has applied for, and expects to receive in the next few months, its’ cultivation and sales licenses under Health Canada’s Access to Cannabis for Medical Purposes Act (“ACMPR”). Atlas’ initial purpose-built 38,000 square foot facility is nearing completion and will have the capacity to produce cannabis concentrates and up to 5,000 kg of dried cannabis annually. Further, the Atlas site could potentially allow for future expansion of up to 6,000,000 square feet of production capacity. Atlas is well financed, and has an unutilized $6.25 million bank facility in place with ATB Financial.
For further information contact:
Jeffrey R. Gossain, P. Eng.
Vice President of OperationsPhone: (780) 784-5920